INSTA RELIEF DM

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: INSTA RELIEF DM
Generic name: LIDOCAINE HYDROCHLORIDE, MENTHOL
Manufacturer: DM LAB CORP
Product type: HUMAN OTC DRUG
SPL set ID: 6ef66fb9-9f49-409d-9503-175c7555ee9e
SPL ID: 097478f1-9b6a-b749-e063-6394a90a9977
Version: 2
Effective date: 2023-11-05
Source export date: 2026-10-30
Source partition: 12
Source file: https://download.open.fda.gov/drug/label/drug-label-0012-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-30/a3e33fe073aa0aa94eb690c6684c74434c63cebfbf7c5530205a2c3e957ecb8b/drug-label-0012-of-0014.json.zip
Source manifest SHA-256: b11f1f6b476c7417db937215bf14307ef1a0b69465b42b411ad52f42ae36ead3
Import run: 20261102T182004Z
Imported at: 2026-11-02 19:38:10

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 12 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M017	openfda.application_number
brand name		INSTA RELIEF DM	openfda.brand_name
generic name		LIDOCAINE HYDROCHLORIDE, MENTHOL	openfda.generic_name
manufacturer name		DM LAB CORP	openfda.manufacturer_name
ndc	package	72465-600-00	openfda.package_ndc
ndc	product	72465-600	openfda.product_ndc
ndc11	package	72465060000	derived:openfda.package_ndc
rxcui		1595624	openfda.rxcui
spl id		097478f1-9b6a-b749-e063-6394a90a9977	id
spl set id		6ef66fb9-9f49-409d-9503-175c7555ee9e	set_id
unii		L7T10EIP3A	openfda.unii
unii		V13007Z41A	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

WARNINGS For external use only. Avoid contact with eyes. If symptoms persist for more than seven days, discontinue use and consult physician. Keep out of reach of children. If swallowed, consult physician. Do not apply to wounds or damaged skin. Do not bandage tightly. If pregnant or breast feeding, contact physician

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.